Results
EORTC Completes Patient Recruitment to Study of Treatment for unresectable or metastatic melanoma
5 Aug 2022
Post
Brussels, August 05, 2022 – The European Organisation for Research and Treatment of Cancer (EORTC) has finished patient recruitment for the EORTC-1612-MG trial in patients with unresected or metastatic melanoma. The randomised trial will study the effect of combined targeted therapy (encorafenib and binimetinib) followed by combined immunotherapy (ipilimumab and nivolumab) as compared to [...]
EORTC Melanoma Group Autumn Meeting
10 Jun 2022
Event
The EORTC Melanoma Group Autumn Meeting will be held in Perugia, Italy on 27-28 October 2022 (face-to-face event). It is only open to individual or site staff members of the group. The link to register was sent by email. Click here to download the preliminary agenda. Click here to view the Melanoma pathobiology course. Venue GRAND HOTEL ASSISI **** Via [...]
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma
24 May 2022
Post
Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) today announced the screening of the first patient with a resected stage II BRAF-mutant melanoma for the phase III study COLUMBUS-AD (NCT05270044; EORTC-2139-MG). COLUMBUS-AD is a pioneering study to evaluate whether the combination of BRAF and MEK inhibitors encorafenib (Braftovi®) and binimetinib [...]
EORTC Melanoma Group Spring Meeting
20 Jan 2022
Event
The EORTC Melanoma Group meeting will be held on 25 March 2022 from 09:00-17:00 CET and is only open to individual or site staff members of the group. Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Melanoma [...]
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
29 Jun 2021
Post
Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients Brussels, Belgium; Castres, France (29 June 2021) – European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients with resected Stage 2 BRAF-mutant melanoma. The [...]
EORTC Melanoma Group Autumn Meeting
14 Jun 2021
Event
The EORTC Melanoma Group meeting will be held on 1 October from 09:00-17:00 CEST and is only open to individual or site staff members of the group. Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Melanoma Group, [...]
